Targeting the synthetic lethal relationship between FOCAD and TUT7 represents a potential therapeutic opportunity for TUT4/7 small molecule inhibitors in cancer.
Triboulet R, Sadykov K, Harvey DM, Wilson DM, Steinbaugh MJ, Mayo CB, Hawley D, Madanjian A, Fyfe C, Bracken C, Rivera-Rivera I, Ericsson A, Snyder AR, Knutson SK, Stein RL, Gibaja V, Ghosh S, Campbell RM.
Triboulet R, et al. Among authors: stein rl.
Mol Cancer Ther. 2024 Sep 5. doi: 10.1158/1535-7163.MCT-24-0176. Online ahead of print.
Mol Cancer Ther. 2024.
PMID: 39235218